Cargando…

Utility of ranolazine in chronic stable angina patients

Chronic stable angina is a debilitating illness affecting at least 6.6 million US residents. Despite being optimally treated by pharmacotherapy and revascularization up to 26% of patients still experience angina. Diabetes mellitus is a common co-morbid condition in angina patients. Several new inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Pawan D, Arora, Rohit R
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597754/ https://www.ncbi.nlm.nih.gov/pubmed/19065998

Ejemplares similares

Update on ranolazine in the management of angina
por: Codolosa, J Nicolás, et al.
Publicado: (2014)

Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris
por: Chaturvedi, Aditi, et al.
Publicado: (2013)

Extended-release ranolazine: critical evaluation of its use in stable angina
por: Truffa, Adriano AM, et al.
Publicado: (2011)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Emerging clinical role of ranolazine in the management of angina
por: Vadnais, David S, et al.
Publicado: (2010)

Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris
por: Aldakkak, Mohammed, et al.
Publicado: (2013)

Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective
por: Coleman, Craig I, et al.
Publicado: (2015)

Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study
por: Kourlaba, Georgia, et al.
Publicado: (2015)

Ranolazine Reduces Patient-Reported Angina Severity and Frequency and Improves Quality of Life in Selected Patients with Chronic Angina
por: Muhlestein, Joseph B., et al.
Publicado: (2013)

Impact of angina frequency on health utility values of patients with chronic stable angina
por: Kohn, Christine G, et al.
Publicado: (2014)

Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria – the ARETHA AT study
por: Zweiker, Robert, et al.
Publicado: (2019)

The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization
por: Calcagno, Simone, et al.
Publicado: (2020)

Improvement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study)
por: Bavry, Anthony A., et al.
Publicado: (2017)

Antianginal Efficacy and Tolerability of Ranolazine as an Add-on Drug to Concomitant Medications Primarily Metoprolol in Chronic Stable Angina Patients: A Prospective, Open-Label Study
por: Khot, Anant Mahaveer, et al.
Publicado: (2017)

Erratum to: Improvement of Subjective Well-Being by Ranolazine in Patients with Chronic Angina and Known Myocardial Ischemia (IMWELL Study)
por: Bavry, Anthony A., et al.
Publicado: (2017)

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
por: Owlia, Mina, et al.
Publicado: (2019)

Management of a patient with chronic stable angina
por: Fox, Kim
Publicado: (2019)

Re chronic stable angina guidelines
por: Gupta, Prabha Nini, et al.
Publicado: (2017)

Ranolazine: A Contemporary Review
por: Rayner‐Hartley, Erin, et al.
Publicado: (2016)

Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023)

Evaluating Symptoms to Improve Quality of Life in Patients with Chronic Stable Angina
por: Young, Jeffrey W., et al.
Publicado: (2013)

Stable Angina
por: Dobesh, Paul P.
Publicado: (2006)

Utility of OCT In a patient with chronic stable angina— “All that is seen using dye is not true”
por: Senguttuvan, Nagendra Boopathy, et al.
Publicado: (2018)

Coronary revascularization in the elderly with stable angina
por: Kozlov, Kirill Lenarovich, et al.
Publicado: (2015)

Ivabradine for the Therapy of Chronic Stable Angina Pectoris
por: Kim, Soo-Joong
Publicado: (2020)

Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis
por: Kaur, Navjot, et al.
Publicado: (2014)

Resolution of Angina Pectoris and Improvement of the Coronary Flow Reserve after Ranolazine Treatment in a Woman with Isolated Impaired Coronary Microcirculation
por: Santoro, Alessandro, et al.
Publicado: (2013)

Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization
por: Kones, Richard
Publicado: (2010)

Mechanism of action of the new anti-ischemia drug ranolazine
por: Hasenfuss, G., et al.
Publicado: (2007)

Enhanced external counterpulsation: A unique treatment for the “No‐Option” refractory angina patient
por: Caceres, Jose, et al.
Publicado: (2021)

Investigation and Management of Stable Angina
por: Underwood, Richard, et al.
Publicado: (1993)

Investigation and Management of Stable Angina
por: Clarke, S E M
Publicado: (1993)

Advances in the Management of Stable Angina
por: Trujillo, Toby C.
Publicado: (2006)

Economic evaluation of trimetazidine in the management of chronic stable angina in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016)

Impact of ranolazine on ventricular arrhythmias – A systematic review
por: Bazoukis, George, et al.
Publicado: (2018)

Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation
por: Verrier, Richard L., et al.
Publicado: (2013)

A Rare Neurological Complication of Ranolazine
por: Porhomayon, Jahan, et al.
Publicado: (2013)

Renal phospholipidosis possibly induced by ranolazine
por: Scheurle, Christoph, et al.
Publicado: (2014)

Improvement of Vascular Insulin Sensitivity by Ranolazine
por: Guerra-Ojeda, Sol, et al.
Publicado: (2023)

Effects of Percutaneous Coronary Intervention on Depressive Symptoms in Chronic Stable Angina Patients
por: Park, Mahn-Won, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5ascsbl54mcdktho5fdvdv6del